ATE102631T1
(de)
*
|
1988-11-11 |
1994-03-15 |
Medical Res Council |
Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
|
DE69730157T2
(de)
*
|
1996-10-17 |
2005-07-28 |
Mitsubishi Chemical Corp. |
Molekül, welches genotyp und phänotyp zusammenführt und dessen anwendungen
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
AU736836B2
(en)
|
1997-07-07 |
2001-08-02 |
Medical Research Council |
In vitro sorting method
|
US6242246B1
(en)
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
US20070166741A1
(en)
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
DE69933369D1
(en)
*
|
1998-04-03 |
2006-11-09 |
Compound Therapeutics Inc |
Adressierbare protein arrays
|
US6440695B1
(en)
*
|
1998-04-17 |
2002-08-27 |
Whitehead Institute For Biomedical Research |
Method for producing diverse libraries of encoded polypeptides
|
US20030170820A1
(en)
*
|
1998-05-08 |
2003-09-11 |
Gregory Coia |
Continuous in- vitro evolution
|
JP4240574B2
(ja)
*
|
1998-05-15 |
2009-03-18 |
三菱化学株式会社 |
タンパク質のラベル化組成物およびタンパク質のラベル化方法
|
US6287765B1
(en)
*
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
WO2000009737A1
(en)
*
|
1998-08-17 |
2000-02-24 |
Phylos, Inc. |
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation
|
AU2004200998B2
(en)
*
|
1998-08-17 |
2007-01-11 |
Compound Therapeutics, Inc. |
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular RNA-protein fusion formation
|
EP1105360B1
(de)
*
|
1998-08-17 |
2009-07-29 |
Bristol-Myers Squibb Company |
Identifizierung von verbindung-protein wechselwirkungen mit bibliotheken von gekoppelten protein-nukleinsäure-molekülen
|
AU775997B2
(en)
*
|
1998-12-02 |
2004-08-19 |
Bristol-Myers Squibb Company |
DNA-protein fusions and uses thereof
|
US6818418B1
(en)
*
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
WO2000034784A1
(en)
|
1998-12-10 |
2000-06-15 |
Phylos, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US7115396B2
(en)
*
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
AU2004242526B2
(en)
*
|
1999-01-07 |
2007-08-30 |
United Kingdom Research And Innovation |
Optical Sorting Method
|
GB9900298D0
(en)
*
|
1999-01-07 |
1999-02-24 |
Medical Res Council |
Optical sorting method
|
US6358713B1
(en)
|
1999-04-12 |
2002-03-19 |
Johns Hopkins University |
In vitro ribosome evolution
|
DE19923966C2
(de)
*
|
1999-05-25 |
2003-04-24 |
Phylos Inc |
Erkennungssystem zur Auftrennung von Probenbestandteilen, seine Herstellung und Verwendung
|
AU779491B2
(en)
|
1999-06-01 |
2005-01-27 |
Bristol-Myers Squibb Company |
Methods for producing 5'-nucleic acid-protein conjugates
|
WO2001004265A2
(en)
|
1999-07-12 |
2001-01-18 |
Phylos, Inc. |
C-terminal protein tagging
|
AU2008200974B2
(en)
*
|
1999-07-27 |
2012-05-03 |
Bristol-Myers Squibb Company |
Peptide acceptor ligation methods
|
PT1870417E
(pt)
*
|
1999-07-27 |
2012-06-01 |
Bristol Myers Squibb Co |
Métodos de ligação de aceitador peptídico
|
JP4803933B2
(ja)
*
|
1999-08-27 |
2011-10-26 |
ブリストル−マイヤーズ スクウィブ カンパニー |
インビトロ翻訳タンパク質の符号化方法および選別方法
|
WO2001025249A1
(en)
*
|
1999-10-01 |
2001-04-12 |
Zhongping Yu |
Compositions and methods for identifying polypeptides and nucleic acid molecules
|
DE19959857C1
(de)
*
|
1999-12-10 |
2001-06-28 |
Aventis Res & Tech Gmbh & Co |
Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung
|
IL150291A0
(en)
*
|
2000-01-11 |
2002-12-01 |
Maxygen Inc |
Integrated systems and methods for diversity generation and screening
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
ATE322558T1
(de)
*
|
2000-01-24 |
2006-04-15 |
Compound Therapeutics Inc |
Sensible und multiplexe diagnostische tests zur proteinanalyse
|
WO2001062983A1
(en)
*
|
2000-02-24 |
2001-08-30 |
Phylos, Inc. |
Improved methods for generating catalytic proteins
|
US6489106B1
(en)
*
|
2000-03-10 |
2002-12-03 |
Nec Research Institute, Inc. |
Control of the expression of anchored genes using micron scale heaters
|
US8288322B2
(en)
|
2000-04-17 |
2012-10-16 |
Dyax Corp. |
Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
|
WO2001083507A1
(en)
*
|
2000-05-05 |
2001-11-08 |
Selegen |
Identification of polypeptides and nucleic acid molecules using linkage between dna and polypeptide
|
US7410761B2
(en)
|
2000-05-19 |
2008-08-12 |
Proteonova, Inc. |
System for rapid identification and selection of nucleic acids and polypeptides, and method thereof
|
US6962781B1
(en)
|
2000-05-19 |
2005-11-08 |
Proteonova, Inc. |
In vitro evolution of nucleic acids and encoded polypeptide
|
EP1290222B1
(de)
*
|
2000-05-19 |
2007-08-08 |
Richard B. Williams |
In vitro evolution von nukleinsäuren und kodierten polypeptiden
|
US20040229271A1
(en)
*
|
2000-05-19 |
2004-11-18 |
Williams Richard B. |
Compositions and methods for the identification and selection of nucleic acids and polypeptides
|
CN102120773B
(zh)
|
2000-06-29 |
2013-07-24 |
Abbvie公司 |
双特异性抗体及其制备方法和用途
|
DE10033194C2
(de)
*
|
2000-07-07 |
2002-07-18 |
Aventis Res & Tech Gmbh & Co |
Biosonden und deren Verwendung
|
DE60120713T2
(de)
*
|
2000-08-15 |
2007-06-06 |
Discerna Ltd. |
Funktionelles protein array
|
DE10041238A1
(de)
*
|
2000-08-22 |
2002-03-07 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Identifizierung spezifisch spaltbarer peptide und Verwendung solcher Peptidsequenzen
|
EP1349946B1
(de)
|
2000-08-25 |
2011-01-26 |
BASF Plant Science GmbH |
Polynukleotide, die für prenylproteasen aus pflanzen kodieren
|
EP1356075A4
(de)
|
2000-10-16 |
2005-04-13 |
Compound Therapeutics Inc |
Proteingerüste für antikörpermimetika und andere bindungsproteine
|
US6841359B2
(en)
|
2000-10-31 |
2005-01-11 |
The General Hospital Corporation |
Streptavidin-binding peptides and uses thereof
|
EP2360275B1
(de)
*
|
2000-11-15 |
2018-03-28 |
Minerva Biotechnologies Corporation |
Oligonukleotididentifikatoren
|
WO2002046395A1
(fr)
|
2000-12-07 |
2002-06-13 |
Keio University |
Proteine a c-terminaison modifiee et procede permettant d'obtenir cette proteine, agent de modification et matrice de traduction necessaire a la production d'une proteine a c-terminaison modifiee, et procede de detection de l'interaction proteique avec l'utilisation de ladite proteine
|
JP4963142B2
(ja)
|
2000-12-14 |
2012-06-27 |
学校法人慶應義塾 |
遺伝子型と表現型の対応付け分子とその構成要素、および対応付け分子の製造方法と利用方法
|
WO2002057294A2
(en)
*
|
2001-01-22 |
2002-07-25 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for dna binding and gene regulation in plants
|
EP1360490B1
(de)
|
2001-01-23 |
2011-12-21 |
President and Fellows of Harvard College |
Nukleinsäure-programmierbare protein-arrays
|
EP2332896A3
(de)
*
|
2001-03-19 |
2012-09-26 |
President and Fellows of Harvard College |
Entwicklung neuer molekularer Funktionen
|
US20040253578A1
(en)
*
|
2001-04-02 |
2004-12-16 |
Roberts Radclyffe L. |
Dynamic action reference tools
|
WO2002083785A1
(en)
*
|
2001-04-10 |
2002-10-24 |
Interlock Industries, Inc. |
Water based adhesive
|
JP2008099700A
(ja)
*
|
2001-05-11 |
2008-05-01 |
National Institute Of Advanced Industrial & Technology |
任意のポリペプチドをコードするDNAの転写産物と翻訳産物との安定的な複合体を形成させる方法、該方法に用いる核酸構築物、該方法により形成される複合体、並びに該方法を利用した機能性タンパク質および該タンパク質をコードするmRNAまたはDNAのスクリーニング
|
DE60221986D1
(de)
*
|
2001-06-20 |
2007-10-04 |
Nuevolution As |
Eine methode zur synthese von matrizenabhängigen molekülen
|
WO2002102820A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
WO2004001042A2
(en)
*
|
2002-06-20 |
2003-12-31 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
US20060234231A1
(en)
*
|
2001-06-20 |
2006-10-19 |
Nuevolution A/S |
Microarrays displaying encoded molecules
|
US20040161741A1
(en)
|
2001-06-30 |
2004-08-19 |
Elazar Rabani |
Novel compositions and processes for analyte detection, quantification and amplification
|
US9777312B2
(en)
|
2001-06-30 |
2017-10-03 |
Enzo Life Sciences, Inc. |
Dual polarity analysis of nucleic acids
|
US20030143612A1
(en)
*
|
2001-07-18 |
2003-07-31 |
Pointilliste, Inc. |
Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
|
WO2003012146A1
(en)
*
|
2001-07-31 |
2003-02-13 |
Phylos, Inc. |
Modular assembly of nucleic acid-protein fusion multimers
|
US7172905B2
(en)
*
|
2001-08-07 |
2007-02-06 |
The University Of Chicago |
Polypeptide immobilization
|
DE10147074A1
(de)
*
|
2001-09-25 |
2003-05-08 |
Beru Ag |
Verfahren zum Betreiben einer aus mehreren Heizelementen bestehenden mehrstufigen elektrischen Heizung
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
ES2327398T3
(es)
|
2001-11-20 |
2009-10-29 |
Duke University |
Biomateriales interfaciales.
|
AU2002365404A1
(en)
*
|
2001-11-27 |
2003-06-10 |
Compound Therapeutics, Inc. |
Solid-phase immobilization of proteins and peptides
|
US7262054B2
(en)
*
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
DE20200926U1
(de)
*
|
2002-01-23 |
2002-04-18 |
Hegenscheidt Mfd Gmbh & Co Kg |
Festwalzgerät einer Festwalzmaschine für Kurbelwellen
|
JP2003299489A
(ja)
*
|
2002-02-08 |
2003-10-21 |
Mitsubishi Chemicals Corp |
核酸構築物
|
EP1481090A4
(de)
*
|
2002-02-15 |
2006-08-09 |
Somalogic Inc |
Verfahren und reagentien zum nachweis der bindung von zielmolekülen durch nukleinsäureliganden
|
EP1487850A2
(de)
*
|
2002-03-15 |
2004-12-22 |
Nuevolution A/S |
Ein baublock zur c-c bindungsbildung oder c-heteroatom bindungsbildung
|
AU2003214031A1
(en)
|
2002-03-15 |
2003-09-29 |
Nuevolution A/S |
An improved method for synthesising templated molecules
|
NO20021298L
(no)
*
|
2002-03-15 |
2003-09-16 |
Bjoern H Lindqvist |
Metoder for peptid og protein påvisning i nukleinsyre chip- arrays
|
EP1487851A2
(de)
*
|
2002-03-15 |
2004-12-22 |
Nuevolution A/S |
Ein baustein geeignet zur funktionellen gruppe übertragung zum nucleophil
|
US20050221318A1
(en)
*
|
2002-03-15 |
2005-10-06 |
Gouliaev Alex H |
Building block forming a c-c bond upon reaction
|
AU2003225085A1
(en)
*
|
2002-04-19 |
2003-11-03 |
California Institute Of Technology |
Unnatural amino acid containing display libraries
|
US20060073481A1
(en)
*
|
2002-04-23 |
2006-04-06 |
The Molecular Sciences Institute |
Formation and use of site specific nucleic acid coupled binding polypeptides
|
US20030198973A1
(en)
*
|
2002-04-23 |
2003-10-23 |
The Molecular Sciences Institute, Inc. |
Chimeric fusion molecule for analyte detection and quantitation
|
US20030198967A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Matson Robert S. |
Multi-functional microarrays and methods
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
WO2004005918A2
(en)
*
|
2002-07-05 |
2004-01-15 |
University Of Chicago |
Characterization of biochips containing self-assembled monolayers with maldi-tof-ms
|
USRE47770E1
(en)
|
2002-07-18 |
2019-12-17 |
Merus N.V. |
Recombinant production of mixtures of antibodies
|
EP2314629B2
(de)
*
|
2002-07-18 |
2022-11-16 |
Merus N.V. |
Rekombinante Herstellung von Mischungen aus Aantikörpern
|
WO2004013070A2
(en)
|
2002-08-01 |
2004-02-12 |
Nuevolution A/S |
Multi-step synthesis of templated molecules
|
JP4657919B2
(ja)
*
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
US20040043384A1
(en)
*
|
2002-08-28 |
2004-03-04 |
Oleinikov Andrew V. |
In vitro protein translation microarray device
|
US7361635B2
(en)
*
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
US7354750B2
(en)
*
|
2002-10-18 |
2008-04-08 |
Promega Corporation |
Methods for separating molecules
|
CN102838654B
(zh)
|
2002-10-30 |
2016-05-18 |
纽韦卢森公司 |
合成双功能复合物的方法
|
AU2011226815B2
(en)
*
|
2002-10-30 |
2014-09-25 |
Nuevolution A/S |
Enzymatic encoding
|
AU2003291964A1
(en)
|
2002-12-19 |
2004-07-14 |
Nuevolution A/S |
Quasirandom structure and function guided synthesis methods
|
US7083948B1
(en)
*
|
2002-12-24 |
2006-08-01 |
Immunex Corporation |
Polypeptide purification reagents and methods for their use
|
EP2159285B1
(de)
|
2003-01-29 |
2012-09-26 |
454 Life Sciences Corporation |
Verfahren zur Verstärkung und Sequenzierung von Nukleinsäuren
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
KR100858081B1
(ko)
*
|
2003-02-14 |
2008-09-10 |
삼성전자주식회사 |
유전정보 코딩장치 및 방법
|
US20070026397A1
(en)
*
|
2003-02-21 |
2007-02-01 |
Nuevolution A/S |
Method for producing second-generation library
|
US20060269920A1
(en)
*
|
2003-02-21 |
2006-11-30 |
Nuevolution A/S |
Method for obtaining structural information about an encoded molecule
|
EP1608748B1
(de)
*
|
2003-03-20 |
2009-03-04 |
Nuevolution A/S |
Ligationsvermittelnde codierung von kleinen molekülen
|
US8017323B2
(en)
*
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
WO2004087730A2
(en)
*
|
2003-03-27 |
2004-10-14 |
The Johns Hopkins University |
Method for producing diverse libraries of encoded polymers
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
WO2004101620A2
(en)
*
|
2003-05-01 |
2004-11-25 |
Compound Therapeutics, Inc. |
Serum albumin scaffold-based proteins and uses thereof
|
CA2527694C
(en)
|
2003-05-30 |
2015-07-14 |
Hendricus Renerus Jacobus Mattheus Hoogenboom |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
WO2004110964A2
(en)
*
|
2003-06-16 |
2004-12-23 |
Nuevolution A/S |
Encoded molecules by translation (emt)
|
WO2005010145A2
(en)
|
2003-07-05 |
2005-02-03 |
The Johns Hopkins University |
Method and compositions for detection and enumeration of genetic variations
|
WO2005042743A2
(en)
|
2003-08-18 |
2005-05-12 |
Medimmune, Inc. |
Humanization of antibodies
|
DK1670939T3
(da)
|
2003-09-18 |
2010-03-01 |
Nuevolution As |
Fremgangsmåde til opnåelse af strukturel information om et kodet molekyle og fremgangsmåde til udvælgelse af forbindelser
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
BRPI0417302A
(pt)
*
|
2003-12-05 |
2007-03-06 |
Compound Therapeutics Inc |
inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
|
CA2554054C
(en)
*
|
2004-01-20 |
2013-06-04 |
Merus B.V. |
Mixtures of binding proteins
|
EP1723255B1
(de)
*
|
2004-02-17 |
2010-12-29 |
Nuevolution A/S |
Anreicherungsverfahren mit eliminierung durch fehlpaarungshybridisierung
|
EP1730277B1
(de)
|
2004-03-22 |
2009-10-28 |
Nuevolution A/S |
Ligationscodierung unter verwendung von oligonukleotidbausteinen
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
JP5053089B2
(ja)
*
|
2004-08-03 |
2012-10-17 |
ベクトン・ディキンソン・アンド・カンパニー |
化合物の直接単離および多成分サンプルの分別のための磁性材料の使用
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
AU2005322131B2
(en)
*
|
2004-12-23 |
2011-11-10 |
Global Life Sciences Solutions Usa Llc |
Ligation-based RNA amplification
|
US10206998B2
(en)
|
2005-01-12 |
2019-02-19 |
Proteonova, Inc. |
Modular targeted therapeutic agents and methods of making same
|
WO2006076417A1
(en)
*
|
2005-01-12 |
2006-07-20 |
Proteonova, Inc. |
Method for making targeted therapeutic agents
|
AU2006227377B2
(en)
|
2005-03-18 |
2013-01-31 |
Medimmune, Llc |
Framework-shuffling of antibodies
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
NZ612578A
(en)
|
2005-08-19 |
2014-11-28 |
Abbvie Inc |
Dual variable domain immunoglobin and uses thereof
|
EP2500355A3
(de)
|
2005-08-19 |
2012-10-24 |
Abbott Laboratories |
Immunglobuline mit zweifacher variabler Domäne und ihre Verwendung
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
CN101277974A
(zh)
|
2005-09-30 |
2008-10-01 |
阿伯特有限及两合公司 |
排斥性引导分子(rgm)蛋白质家族的蛋白质的结合结构域及其功能性片段和它们的用途
|
EP1785434A1
(de)
|
2005-11-11 |
2007-05-16 |
Ludwig-Maximilians-Universität München |
Zielen und Folgen von Antigenen in lebenden Zellen
|
US7705138B2
(en)
*
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
AU2006315438A1
(en)
|
2005-11-11 |
2007-05-24 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
KR20080079643A
(ko)
|
2005-11-16 |
2008-09-01 |
암브룩스, 인코포레이티드 |
비-천연 아미노산을 포함하는 방법 및 조성물
|
WO2007064972A2
(en)
|
2005-11-30 |
2007-06-07 |
Abbott Laboratories |
Monoclonal antibodies against amyloid beta protein and uses thereof
|
ES2524984T3
(es)
|
2005-11-30 |
2014-12-16 |
Abbvie Inc. |
Anticuerpos anti-globulómero a?, porciones de unión a antígeno de estos, hibridomas correspondientes, ácidos nucleicos, vectores, células huésped, métodos para producir dichos anticuerpos, composiciones que comprenden dichos anticuerpos, usos de dichos anticuerpos, y métodos para usar dichos anticuerpos
|
SI3305900T1
(sl)
|
2005-12-01 |
2022-02-28 |
Nuevolution A/S |
Postopki encimskega kodiranja za učinkovito sintezo velikih knjižnic
|
US20080305559A1
(en)
*
|
2005-12-15 |
2008-12-11 |
Gualberto Gonzalez-Sapienza |
Non-Competitive Immunoassays to Detect Small Molecules
|
WO2007081387A1
(en)
|
2006-01-11 |
2007-07-19 |
Raindance Technologies, Inc. |
Microfluidic devices, methods of use, and kits for performing diagnostics
|
TWI507528B
(zh)
*
|
2006-01-17 |
2015-11-11 |
Somalogic Inc |
測試樣品的多重分析方法
|
EP1987064A4
(de)
|
2006-02-01 |
2010-04-07 |
Arana Therapeutics Ltd |
Domänen-antikörper-konstrukt
|
WO2007092777A2
(en)
*
|
2006-02-02 |
2007-08-16 |
Wyeth |
Cloning, characterization, and application of tnfrsf19 in neurological disorders
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
WO2007133710A2
(en)
|
2006-05-11 |
2007-11-22 |
Raindance Technologies, Inc. |
Microfluidic devices and methods of use thereof
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
US8178316B2
(en)
|
2006-06-29 |
2012-05-15 |
President And Fellows Of Harvard College |
Evaluating proteins
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
JP5415264B2
(ja)
|
2006-06-30 |
2014-02-12 |
ドイスコベルク コーポレーション |
検出可能な核酸タグ
|
WO2008016680A1
(en)
*
|
2006-08-02 |
2008-02-07 |
California Institute Of Technology |
Methods and systems for detecting and/or sorting targets
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
CA2914170C
(en)
|
2006-09-08 |
2018-10-30 |
Abbvie Bahamas Ltd. |
Interleukin-13 binding proteins
|
US20090252745A1
(en)
*
|
2006-09-15 |
2009-10-08 |
Duke University |
Amino acids in the HCV core polypeptide domain 3 and correlation with steatosis
|
BRPI0719597A2
(pt)
|
2006-11-22 |
2013-12-17 |
Adnexus A Bristol Myers Squibb R & D Company |
Produtos terapêuticos objetivados baseados em proteínas manipuladas para receptores de quinases de tirosina, incluindo igf-ir
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
US8324350B2
(en)
|
2006-12-29 |
2012-12-04 |
Abbott Laboratories |
Dual-specific IL-1α/IL-1β antibodies
|
US20110136099A1
(en)
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
US7855054B2
(en)
*
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
EP2111228B1
(de)
|
2007-02-02 |
2011-07-20 |
Bristol-Myers Squibb Company |
10Fn3 Domain zur Behandlung von Krankheiten begleitet von unerwünschter Angiogenese
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
CA2677804C
(en)
|
2007-02-12 |
2017-03-14 |
Proteonova, Inc. |
Generation of library of soluble random polypeptides linked to mrna
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7678883B2
(en)
*
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US8470966B2
(en)
|
2007-08-10 |
2013-06-25 |
Protelica, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8680019B2
(en)
*
|
2007-08-10 |
2014-03-25 |
Protelica, Inc. |
Universal fibronectin Type III binding-domain libraries
|
US20090176654A1
(en)
*
|
2007-08-10 |
2009-07-09 |
Protelix, Inc. |
Universal fibronectin type III binding-domain libraries
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
BRPI0816785A2
(pt)
|
2007-09-14 |
2017-05-02 |
Adimab Inc |
bibliotecas de anticorpos sintéticos racionalmente desenhadas, e, usos para as mesmas
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
DK2567709T3
(en)
|
2007-11-02 |
2018-03-12 |
Novartis Ag |
Molecules and Methods for Modulating Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6)
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
WO2009073569A2
(en)
|
2007-11-30 |
2009-06-11 |
Abbott Laboratories |
Protein formulations and methods of making same
|
WO2009075773A2
(en)
*
|
2007-12-07 |
2009-06-18 |
Goldstein Steven A |
Identification of toxin ligands
|
US8524244B2
(en)
|
2008-02-14 |
2013-09-03 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins that bind EGFR
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
US9873957B2
(en)
|
2008-03-13 |
2018-01-23 |
Dyax Corp. |
Libraries of genetic packages comprising novel HC CDR3 designs
|
EP3141905B1
(de)
|
2008-03-27 |
2019-03-06 |
Promega Corporation |
Proteinetikettierung mit cyanbenzothiazol-konjugaten
|
ES2528963T3
(es)
|
2008-04-24 |
2015-02-13 |
Dyax Corp. |
Bibliotecas de paquetes genéticos que comprenden nuevos diseños de CDR1, CDR2, y CDR3 de HC y nuevos diseños de CDR1, CDR2, y CDR3 de LC
|
CN104479017A
(zh)
|
2008-04-25 |
2015-04-01 |
戴埃克斯有限公司 |
针对fcrn的抗体及其用途
|
BRPI0910482A2
(pt)
|
2008-04-29 |
2019-09-24 |
Abbott Lab |
imunoglobinas de domínio variável duplo e usos das mesmas
|
WO2009135214A2
(en)
*
|
2008-05-02 |
2009-11-05 |
Epicentre Technologies Corporation |
Rna polyphosphatase compositions, kits, and uses thereof
|
MX2010012142A
(es)
|
2008-05-09 |
2011-04-05 |
Abbott Gmbh & Co Kg |
Anticuerpos para receptor de productos finales de glucacion avanzada (rage) y usos de los mismos.
|
JP2011520961A
(ja)
|
2008-05-22 |
2011-07-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
多価フィブロネクチンをベースとする足場ドメインタンパク質
|
JP5723769B2
(ja)
|
2008-06-03 |
2015-05-27 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリン及びその使用
|
JP2011523853A
(ja)
|
2008-06-03 |
2011-08-25 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリン及びその使用
|
RU2582244C2
(ru)
|
2008-06-30 |
2016-04-20 |
ИЭсБиЭйТЕК, ЭН АЛЬКОН БАЙОМЕДИКАЛ РИСЕРЧ ЮНИТ ЭлЭлСи |
Функционализированные полипептиды
|
BRPI0915825A2
(pt)
|
2008-07-08 |
2015-11-03 |
Abbott Lab |
proteínas de ligação à prostaglandina e2 usos das mesmas
|
BRPI0915448A2
(pt)
|
2008-07-08 |
2015-11-10 |
Abbott Lab |
imunoglobulinas de domínio variável duplo para prostaglandina e2 e usos das mesmas
|
WO2010009365A1
(en)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Droplet libraries
|
EP2316030B1
(de)
|
2008-07-25 |
2019-08-21 |
Wagner, Richard W. |
Proteinscreeningverfahren
|
CN102227440A
(zh)
*
|
2008-09-30 |
2011-10-26 |
雅培制药有限公司 |
改良的抗体文库
|
EP2349329A4
(de)
|
2008-10-14 |
2012-10-31 |
Dyax Corp |
Verwendung von igf-ii/igf-iie-bindung zur behandlung und prävention von systemischer sklerose im zusammenhang mit lungenfibrose
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之egfr/igfir結合分子
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
US8697654B2
(en)
|
2008-12-18 |
2014-04-15 |
E I Du Pont De Nemours And Company |
Peptide linkers for effective multivalent peptide binding
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158822A1
(en)
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
CN101768213B
(zh)
|
2008-12-30 |
2012-05-30 |
中国科学院遗传与发育生物学研究所 |
一种与植物分蘖数目相关的蛋白及其编码基因与应用
|
US9359601B2
(en)
|
2009-02-13 |
2016-06-07 |
X-Chem, Inc. |
Methods of creating and screening DNA-encoded libraries
|
CN101817879A
(zh)
|
2009-02-26 |
2010-09-01 |
中国科学院遗传与发育生物学研究所 |
金属硫蛋白及其编码基因与应用
|
EP3235509A1
(de)
|
2009-03-05 |
2017-10-25 |
AbbVie Inc. |
Il-17-bindende proteine
|
US8528589B2
(en)
|
2009-03-23 |
2013-09-10 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
US20100247590A1
(en)
*
|
2009-03-30 |
2010-09-30 |
Johnson & Johnson |
Peptide-Based Systems For Delivery Of Cosmetic Agents
|
US8067201B2
(en)
|
2009-04-17 |
2011-11-29 |
Bristol-Myers Squibb Company |
Methods for protein refolding
|
JP2012524907A
(ja)
|
2009-04-24 |
2012-10-18 |
ディスカヴァーエックス コーポレイション |
検出可能なタンパク質を用いた細胞分析
|
WO2010127186A1
(en)
|
2009-04-30 |
2010-11-04 |
Prognosys Biosciences, Inc. |
Nucleic acid constructs and methods of use
|
PE20121647A1
(es)
|
2009-08-29 |
2012-12-31 |
Abbvie Inc |
Proteinas terapeuticas de union a dll4
|
AU2010289527C1
(en)
|
2009-09-01 |
2014-10-30 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
US20110082054A1
(en)
*
|
2009-09-14 |
2011-04-07 |
Dyax Corp. |
Libraries of genetic packages comprising novel hc cdr3 designs
|
EP2486408A4
(de)
*
|
2009-10-05 |
2013-04-24 |
Opsonic Therapeutics Inc |
Hochaffine adaptermoleküle zur umleitung von antikörperspezifitäten
|
EP2486409A1
(de)
|
2009-10-09 |
2012-08-15 |
Universite De Strasbourg |
Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
|
JP2013507928A
(ja)
|
2009-10-15 |
2013-03-07 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびその使用
|
US20120208720A1
(en)
|
2009-10-22 |
2012-08-16 |
Kenji Kashiwagi |
Rapid display method in translational synthesis of peptide
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
EP2494046B1
(de)
|
2009-10-30 |
2018-09-12 |
Novartis AG |
Unterseitig bindende universelle fibronectin-typ-iii-domänenbibliotheken
|
TW201121568A
(en)
|
2009-10-31 |
2011-07-01 |
Abbott Lab |
Antibodies to receptor for advanced glycation end products (RAGE) and uses thereof
|
WO2011054893A2
(en)
|
2009-11-05 |
2011-05-12 |
Novartis Ag |
Biomarkers predictive of progression of fibrosis
|
WO2011058087A1
(en)
|
2009-11-11 |
2011-05-19 |
Gentian As |
Immunoassay for assessing related analytes of different origin
|
JP2013512672A
(ja)
|
2009-12-02 |
2013-04-18 |
アムジエン・インコーポレーテツド |
ヒトFGFR1c、ヒトβ−クロト−、ならびにヒトFGFR1cおよびヒトβ−クロト−の両方に結合する結合タンパク質
|
JP2013512691A
(ja)
*
|
2009-12-07 |
2013-04-18 |
プログノシス バイオサイエンシズ インコーポレイテッド |
ペプチド提示アレイ
|
PL2510001T3
(pl)
|
2009-12-08 |
2016-06-30 |
Abbvie Deutschland |
Monoklonalne przeciwciało przeciwko białku RGM A do zastosowania w leczeniu zwyrodnienia warstwy włókien nerwowych siatkówki (RNFL)
|
WO2011079176A2
(en)
|
2009-12-23 |
2011-06-30 |
Raindance Technologies, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
CA3021759A1
(en)
|
2010-01-06 |
2011-07-14 |
Dyax Corp. |
Plasma kallikrein binding proteins
|
CA2789125A1
(en)
|
2010-02-10 |
2011-08-18 |
Novartis Ag |
Methods and compounds for muscle growth
|
CA2789425C
(en)
|
2010-02-12 |
2020-04-28 |
Raindance Technologies, Inc. |
Digital analyte analysis with polymerase error correction
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
PE20130041A1
(es)
|
2010-02-18 |
2013-01-28 |
Bristol Myers Squibb Co |
Proteinas de dominio de andamiaje de fibronectina que se unen a interleucina 23 (il-23)
|
JP5964249B2
(ja)
|
2010-03-02 |
2016-08-03 |
アッヴィ・インコーポレイテッド |
治療用dll4結合タンパク質
|
CA2794522C
(en)
|
2010-04-05 |
2019-11-26 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
CA2796338C
(en)
|
2010-04-13 |
2020-03-24 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind pcsk9
|
JP2013523182A
(ja)
|
2010-04-15 |
2013-06-17 |
アボット・ラボラトリーズ |
アミロイドベータ結合タンパク質
|
SI2558577T1
(sl)
|
2010-04-16 |
2019-05-31 |
Nuevolution A/S |
Bifunkcionalni kompleksi in metode za pripravo in uporabo takšnih kompleksov
|
TW201138808A
(en)
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
TWI615405B
(zh)
|
2010-05-14 |
2018-02-21 |
艾伯維有限公司 |
Il-1結合蛋白
|
EP3091028A1
(de)
|
2010-05-26 |
2016-11-09 |
Bristol-Myers Squibb Company |
Auf fibronectin basierende gerüstproteine mit erhöhter stabilität
|
US20120009196A1
(en)
|
2010-07-08 |
2012-01-12 |
Abbott Laboratories |
Monoclonal antibodies against hepatitis c virus core protein
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
EP2593594B1
(de)
|
2010-07-16 |
2017-09-27 |
Adimab, LLC |
Antikörperbibliotheken
|
US9512199B2
(en)
|
2010-07-30 |
2016-12-06 |
Novartis Ag |
Fibronectin cradle molecules and libraries thereof
|
CN103298834A
(zh)
|
2010-08-03 |
2013-09-11 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US9062101B2
(en)
|
2010-08-14 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
WO2012024650A2
(en)
|
2010-08-19 |
2012-02-23 |
Abbott Laboratories |
Anti-ngf antibodies and their use
|
AU2011293253B2
(en)
|
2010-08-26 |
2014-12-11 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
EP2622103B2
(de)
|
2010-09-30 |
2022-11-16 |
Bio-Rad Laboratories, Inc. |
Sandwichassays in tröpfchen
|
EP2625189B1
(de)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Manipulierte nukleinsäuren und anwendungsverfahren dafür
|
WO2012052391A1
(en)
|
2010-10-19 |
2012-04-26 |
Glaxo Group Limited |
Polypeptide with jmjd3 catalytic activity
|
JP6224456B2
(ja)
|
2010-11-05 |
2017-11-01 |
モルフォテック、インク. |
葉酸受容体アルファ発現癌の診断および予後マーカーとしての葉酸受容体アルファ
|
EP2647720B1
(de)
*
|
2010-12-03 |
2019-06-19 |
The University of Tokyo |
Peptidbibliothek-herstellungsverfahren, peptidbibliothek und screening-verfahren
|
JP6004399B2
(ja)
|
2010-12-03 |
2016-10-05 |
国立大学法人 東京大学 |
安定化された二次構造を有するペプチド、及びペプチドライブラリー、それらの製造方法
|
TW201307388A
(zh)
|
2010-12-21 |
2013-02-16 |
Abbott Lab |
Il-1結合蛋白
|
JP6009455B2
(ja)
|
2010-12-21 |
2016-10-19 |
アッヴィ・インコーポレイテッド |
Il−1アルファおよびベータ二重特異的二重可変ドメイン免疫グロブリンおよびその使用
|
WO2012088006A1
(en)
|
2010-12-22 |
2012-06-28 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domain proteins that bind il-23
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
EP2673614B1
(de)
|
2011-02-11 |
2018-08-01 |
Raindance Technologies, Inc. |
Verfahren zur bildung gemischter tröpfchen
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
WO2012125652A2
(en)
|
2011-03-14 |
2012-09-20 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
US9880160B2
(en)
|
2011-03-15 |
2018-01-30 |
X-Body, Inc. |
Antibody screening methods
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
US20120258871A1
(en)
|
2011-04-08 |
2012-10-11 |
Prognosys Biosciences, Inc. |
Peptide constructs and assay systems
|
EP3415528B1
(de)
|
2011-04-13 |
2021-05-26 |
Bristol-Myers Squibb Company |
Fc-fusionsproteine mit neuartigen linkern oder anordnungen
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
EP3415619B1
(de)
|
2011-04-28 |
2020-12-16 |
The Board of Trustees of the Leland Stanford Junior University |
Identifizierung von mit einer probe assoziierten polynukleotiden
|
EP2709669A1
(de)
|
2011-05-17 |
2014-03-26 |
Bristol-Myers Squibb Company |
Verfahren zur aufrechterhaltung der pegylierung von polypeptiden
|
WO2012158739A1
(en)
|
2011-05-17 |
2012-11-22 |
Bristol-Myers Squibb Company |
Improved methods for the selection of binding proteins
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP2714084B1
(de)
|
2011-06-02 |
2019-05-22 |
Dyax Corp. |
Fc-REZEPTOR-BINDENDE PROTEINE
|
EP3216872B1
(de)
|
2011-06-02 |
2020-04-01 |
Bio-Rad Laboratories, Inc. |
Enzymquantifizierung
|
EP2715345A1
(de)
|
2011-06-02 |
2014-04-09 |
Massachusetts Institute of Technology |
Dsrna/dna-hybridgenomreplikationszwischenprodukt von metakaryotischen stammzellen
|
AU2012283039A1
(en)
|
2011-07-13 |
2014-01-30 |
Abbvie Inc. |
Methods and compositions for treating asthma using anti-IL-13 antibodies
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
EP2742153B1
(de)
|
2011-08-01 |
2018-09-05 |
The General Hospital Corporation |
Protein- und peptidbibliotheken
|
IN2014CN02574A
(de)
|
2011-09-07 |
2015-06-26 |
Chem Inc X |
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
HUE057725T2
(hu)
|
2011-10-03 |
2022-06-28 |
Modernatx Inc |
Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
|
WO2013063114A1
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Immunobinders directed against tnf
|
CA2853258A1
(en)
|
2011-10-24 |
2013-05-02 |
Abbvie Inc. |
Immunobinders directed against sclerostin
|
EP2773659A2
(de)
|
2011-10-31 |
2014-09-10 |
Bristol-Myers Squibb Company |
Fibronectinbindungsdomänen mit verminderter immunogenität
|
US9416179B2
(en)
|
2011-12-05 |
2016-08-16 |
X-Body, Inc. |
PDGF receptor beta binding polypeptides
|
AU2012352168C1
(en)
|
2011-12-14 |
2018-01-25 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
WO2013090633A2
(en)
|
2011-12-14 |
2013-06-20 |
AbbVie Deutschland GmbH & Co. KG |
Composition and method for the diagnosis and treatment of iron-related disorders
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
EP2813512B1
(de)
*
|
2011-12-28 |
2021-03-31 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur zyklisierung einer peptidverbindung
|
JP2015508994A
(ja)
|
2011-12-30 |
2015-03-26 |
アッヴィ・インコーポレイテッド |
Il−13および/またはil−17に対する二重可変ドメイン免疫グロブリン
|
IL305223A
(en)
|
2012-01-27 |
2023-10-01 |
Abbvie Inc |
The composition and method for the diagnosis and treatment of diseases related to the degeneration of nerve cells
|
GB2500243A
(en)
*
|
2012-03-15 |
2013-09-18 |
Isogenica Ltd |
Identifying members of immobilised peptide libraries comprising protein-DNA complexes
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
AU2013243947A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
JP6393255B2
(ja)
|
2012-04-20 |
2018-09-19 |
メルス ナムローゼ フェンノートシャップ |
ヘテロ二量体のIgG様分子を生産する方法、ヘテロ二量体のIgG様分子、ヘテロ二量体の抗体、組み換え宿主細胞、医薬組成物、宿主細胞を作成する方法、および培養物
|
WO2013172954A1
(en)
|
2012-05-17 |
2013-11-21 |
Ra Pharmaceuticals, Inc |
Peptide and peptidomimetic inhibitors
|
EP2859018B1
(de)
|
2012-06-06 |
2021-09-22 |
Zoetis Services LLC |
Anti-ngf-antikörper für hunde und verfahren dafür
|
TW201402608A
(zh)
|
2012-07-12 |
2014-01-16 |
Abbvie Inc |
Il-1結合蛋白質
|
AU2013289993B2
(en)
|
2012-07-13 |
2018-05-10 |
X-Chem, Inc. |
DNA-encoded libraries having encoding oligonucleotide linkages not readable by polymerases
|
IL270110B
(en)
|
2012-09-13 |
2022-08-01 |
Bristol Myers Squibb Co |
Proteins based on the scaffolding domain of fibronectin that bind to myostatin
|
BR112015009961B1
(pt)
|
2012-11-01 |
2020-10-20 |
Abbvie Inc. |
proteína de ligação capaz de se ligar a dll4 e vegf, bem como composição que a compreende como composição que a compreende
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
US9550986B2
(en)
|
2012-12-21 |
2017-01-24 |
Abbvie Inc. |
High-throughput antibody humanization
|
JPWO2014119600A1
(ja)
|
2013-01-30 |
2017-01-26 |
ペプチドリーム株式会社 |
FlexibleDisplay法
|
US20150361159A1
(en)
|
2013-02-01 |
2015-12-17 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold proteins
|
EP3406629B1
(de)
|
2013-02-06 |
2020-06-24 |
Bristol-Myers Squibb Company |
Fibronectin-typ-iii-domain-proteine mit verbesserter löslichkeit
|
WO2014126884A1
(en)
|
2013-02-12 |
2014-08-21 |
Bristol-Myers Squibb Company |
High ph protein refolding methods
|
JP6416793B2
(ja)
|
2013-02-28 |
2018-10-31 |
カプリオン プロテオミクス インコーポレーテッド |
結核のバイオマーカー及びその使用
|
WO2014165093A2
(en)
|
2013-03-13 |
2014-10-09 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
US10132816B2
(en)
|
2013-03-14 |
2018-11-20 |
Beth Israel Deaconess Medical Center, Inc. |
Measurement of FGF21 as a biomarker of fructose metabolism
|
CA2906407A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbott Laboratories |
Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
|
WO2014158272A1
(en)
|
2013-03-14 |
2014-10-02 |
Abbott Laboratories |
Hcv antigen-antibody combination assay and methods and compositions for use therein
|
CN113549148A
(zh)
|
2013-03-14 |
2021-10-26 |
雅培制药有限公司 |
Hcv核心脂质结合结构域单克隆抗体
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
US9062108B2
(en)
|
2013-03-15 |
2015-06-23 |
Abbvie Inc. |
Dual specific binding proteins directed against IL-1 and/or IL-17
|
WO2014145047A1
(en)
|
2013-03-15 |
2014-09-18 |
Prognosys Biosciences, Inc. |
Methods for detecting peptide/mhc/tcr binding
|
US9469686B2
(en)
|
2013-03-15 |
2016-10-18 |
Abbott Laboratories |
Anti-GP73 monoclonal antibodies and methods of obtaining the same
|
EP3567123B1
(de)
|
2013-05-20 |
2021-11-10 |
BioVentures, LLC |
Gep5-modell für multiples myelom
|
JP6581572B2
(ja)
|
2013-06-07 |
2019-09-25 |
デューク ユニバーシティ |
補体因子h阻害薬
|
EP3013984B1
(de)
|
2013-06-25 |
2023-03-22 |
Prognosys Biosciences, Inc. |
Verfahren zur bestimmung der räumlichen muster biologischer ziele in einer probe
|
AU2014302811B2
(en)
|
2013-06-28 |
2020-01-23 |
X-Body, Inc. |
Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
|
WO2015034928A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
EP3779440A1
(de)
|
2013-09-23 |
2021-02-17 |
X-Body, Inc. |
Verfahren und zusammensetzungen zur erzeugung von bindemitteln gegen zelloberflächenantigene
|
EP3052106A4
(de)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynukleotide zur codierung immunmodulierender polypeptide
|
EP3052521A1
(de)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynukleotide zur codierung von low-density-lipoprotein-rezeptor
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
WO2015070037A2
(en)
|
2013-11-08 |
2015-05-14 |
Prognosys Biosciences, Inc. |
Polynucleotide conjugates and methods for analyte detection
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
CN116478927A
(zh)
|
2013-12-19 |
2023-07-25 |
诺华股份有限公司 |
人间皮素嵌合抗原受体及其用途
|
GB201322692D0
(en)
|
2013-12-20 |
2014-02-05 |
Philochem Ag |
Production of encoded chemical libraries
|
EP3090063B1
(de)
|
2013-12-31 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Verfahren zur detektion von latentem retrovirus
|
EP3102245B1
(de)
|
2014-02-05 |
2021-09-08 |
Molecular Templates, Inc. |
Verfahren zum abtasten, auswählen und identifizieren von cytotoxischen rekombinanten polypeptiden auf grundlage einer vorläufigen minderung der ribotoxizität
|
AU2015231170B2
(en)
|
2014-03-20 |
2019-10-03 |
Bristol-Myers Squibb Company |
Serum albumin-binding fibronectin type III domains
|
MX371403B
(es)
|
2014-03-20 |
2020-01-29 |
Bristol Myers Squibb Co |
Moleculas de andamiaje a base de fibronectina estabilizada.
|
PT3154561T
(pt)
|
2014-06-12 |
2019-10-25 |
Ra Pharmaceuticals Inc |
Modulação da actividade do complemento.
|
US10562946B2
(en)
|
2014-06-20 |
2020-02-18 |
Genentech, Inc. |
Chagasin-based scaffold compositions, methods, and uses
|
US20170204152A1
(en)
|
2014-07-16 |
2017-07-20 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
EP3722316A1
(de)
|
2014-07-21 |
2020-10-14 |
Novartis AG |
Behandlung von krebs unter verwendung eines chimären cd33-antigenrezeptors
|
EP3180359A1
(de)
|
2014-08-14 |
2017-06-21 |
Novartis AG |
Behandlung von krebs mit einem chimären gfr-alpha-4-antigenrezeptor
|
HUE049218T2
(hu)
|
2014-08-19 |
2020-10-28 |
Novartis Ag |
Anti-CD123 kiméra antigénreceptor (CAR) rák kezelésében történõ alkalmazásra
|
MA40772A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus de la grippe a
|
MA40773A
(fr)
|
2014-10-02 |
2017-08-08 |
Vertex Pharma |
Variants du virus influenza a
|
AU2015353573B2
(en)
|
2014-11-25 |
2020-09-03 |
Bristol-Myers Squibb Company |
Novel PD-L1 binding polypeptides for imaging
|
CA2968961A1
(en)
|
2014-11-25 |
2016-06-02 |
Bristol-Myers Squibb Company |
Methods and compositions for 18f-radiolabeling of biologics
|
WO2016094881A2
(en)
|
2014-12-11 |
2016-06-16 |
Abbvie Inc. |
Lrp-8 binding proteins
|
HRP20211824T1
(hr)
|
2015-01-28 |
2022-03-04 |
Ra Pharmaceuticals, Inc. |
Modulatori aktivnosti komplementa
|
EP3061826A1
(de)
|
2015-02-27 |
2016-08-31 |
Novartis AG |
Flavivirus-replikons
|
EP4166664A1
(de)
|
2015-03-13 |
2023-04-19 |
Chugai Seiyaku Kabushiki Kaisha |
Modifizierte aminoacyl-trna-synthetase und verwendung davon
|
EP3280444B1
(de)
|
2015-04-10 |
2024-05-08 |
Adimab, LLC |
Verfahren zur reinigung heterodimerer multispezifischer antikörper aus elterlichen homodimeren antikörperarten
|
EP3530752B1
(de)
|
2015-04-10 |
2021-03-24 |
Spatial Transcriptomics AB |
Räumlich getrennte multiplex-nukleinsäureanalyse von biologischen proben
|
CN104774801A
(zh)
*
|
2015-04-14 |
2015-07-15 |
云南农业大学 |
一种核酸核糖体结合体系构建方法及应用
|
CA2983276A1
(en)
|
2015-04-24 |
2016-10-27 |
Viiv Healthcare Uk (No 5) Limited |
Polypeptides targeting hiv fusion
|
JP6952605B2
(ja)
|
2015-04-24 |
2021-10-20 |
ジェネンテック, インコーポレイテッド |
多特異性抗原結合タンパク質
|
PT3303395T
(pt)
|
2015-05-29 |
2020-02-20 |
Abbvie Inc |
Anticorpos anti-cd40 e usos dos mesmos
|
TW201710286A
(zh)
|
2015-06-15 |
2017-03-16 |
艾伯維有限公司 |
抗vegf、pdgf及/或其受體之結合蛋白
|
US20190008887A1
(en)
*
|
2015-07-30 |
2019-01-10 |
ModernaTX Inc. |
Multimeric mrna
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
WO2017053619A1
(en)
|
2015-09-23 |
2017-03-30 |
Bristrol-Myers Squibb Company |
Glypican-3binding fibronectin based scafflold molecules
|
EP3353199B1
(de)
|
2015-09-23 |
2020-02-19 |
Bristol-Myers Squibb Company |
Schnell ablaufende serumalbumin-bindende fibronektin-typ-iii-domänen
|
JP7126940B2
(ja)
|
2015-12-16 |
2022-08-29 |
ラ ファーマシューティカルズ インコーポレイテッド |
補体活性のモジュレーター
|
WO2017165742A1
(en)
|
2016-03-24 |
2017-09-28 |
Millennium Pharmaceuticals, Inc. |
Methods of treating gastrointestinal immune-related adverse events in anti-ctla4 anti-pd-1 combination treatments
|
JP7069032B2
(ja)
|
2016-03-24 |
2022-05-17 |
ミレニアム ファーマシューティカルズ, インコーポレイテッド |
がん免疫治療における胃腸の免疫関連有害事象の治療方法
|
KR20230047506A
(ko)
*
|
2016-05-02 |
2023-04-07 |
엔코디아, 인코포레이티드 |
암호화 핵산을 사용한 거대분자 분석
|
US10994033B2
(en)
|
2016-06-01 |
2021-05-04 |
Bristol-Myers Squibb Company |
Imaging methods using 18F-radiolabeled biologics
|
WO2017210302A1
(en)
|
2016-06-01 |
2017-12-07 |
Bristol-Myers Squibb Company |
Pet imaging with pd-l1 binding polypeptides
|
CA3028002A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
JP7219376B2
(ja)
|
2016-07-15 |
2023-02-08 |
ノバルティス アーゲー |
キメラ抗原受容体をキナーゼ阻害薬と併用して使用したサイトカイン放出症候群の治療及び予防
|
US20180106800A1
(en)
|
2016-10-03 |
2018-04-19 |
Abbott Laboratories |
Methods of assessing uch-l1 status in patient samples
|
WO2018067992A1
(en)
|
2016-10-07 |
2018-04-12 |
Novartis Ag |
Chimeric antigen receptors for the treatment of cancer
|
TW201836634A
(zh)
|
2016-12-07 |
2018-10-16 |
美商Ra製藥公司 |
補體活性之調節劑
|
CN110312530A
(zh)
|
2017-01-13 |
2019-10-08 |
中央研究院 |
用以治疗心肌梗塞的可重复装载的水胶***
|
TWI659751B
(zh)
|
2017-01-13 |
2019-05-21 |
中央研究院 |
用以治療腦部疾病之可重複裝載之改良水膠系統
|
WO2018168999A1
(ja)
|
2017-03-17 |
2018-09-20 |
国立研究開発法人理化学研究所 |
Rna分子とペプチドとの複合体の製造方法、及びその利用
|
JP7346300B2
(ja)
|
2017-03-23 |
2023-09-19 |
アボット・ラボラトリーズ |
早期バイオマーカーであるユビキチンカルボキシ末端ヒドロラーゼl1を使用する、ヒト対象における外傷性脳損傷の程度の診断及び決定の一助となるための方法
|
CA3053409A1
(en)
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
JP7080899B2
(ja)
|
2017-04-28 |
2022-06-06 |
アボット・ラボラトリーズ |
同じヒト対象に由来する少なくとも2つの試料に対して早期バイオマーカーを使用する、外傷性脳損傷の超急性の診断及び決定の一助となるための方法
|
US10865238B1
(en)
|
2017-05-05 |
2020-12-15 |
Duke University |
Complement factor H antibodies
|
EP3631465A1
(de)
|
2017-05-25 |
2020-04-08 |
Abbott Laboratories |
Verfahren mit frühen biomarkern zur unterstützung bei der entscheidung, ob bei einer person, die eine kopfverletzung erlitten hat oder erlitten haben könnte, eine bildgebung durchgeführt werden soll
|
EP3933408A1
(de)
|
2017-05-30 |
2022-01-05 |
Nant Holdings IP LLC |
Zirkulierende tumorzellenanreicherung unter verwendung von neoepitopen
|
WO2018222783A1
(en)
|
2017-05-30 |
2018-12-06 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
|
WO2018225851A1
(ja)
|
2017-06-09 |
2018-12-13 |
中外製薬株式会社 |
N-置換アミノ酸を含むペプチドの合成方法
|
JP7454945B2
(ja)
|
2017-07-03 |
2024-03-25 |
アボット・ラボラトリーズ |
血液中のユビキチンカルボキシ末端ヒドロラーゼl1レベルを測定するための、改善された方法
|
KR20210027230A
(ko)
|
2017-10-04 |
2021-03-10 |
옵코 파마슈티칼스, 엘엘씨 |
암의 개인 맞춤형 치료에 관한 물품 및 방법
|
KR102556494B1
(ko)
*
|
2017-10-31 |
2023-07-18 |
엔코디아, 인코포레이티드 |
핵산 암호화 및/또는 표지를 이용한 분석용 키트
|
BR112020010085A2
(pt)
|
2017-12-09 |
2020-10-13 |
Abbott Laboratories |
métodos para auxiliar no diagnóstico e avaliar uma lesão cerebral traumática em um indivíduo humano usando uma combinação de gfap e uch-l1
|
BR112019028254A2
(pt)
|
2017-12-09 |
2020-07-14 |
Abbott Laboratories |
métodos para ajudar no diagnóstico e avaliação de um paciente que sofreu uma lesão ortopédica e que sofreu ou pode ter sofrido uma lesão na cabeça, tal como uma lesão cerebral traumática (lct) leve, usando a proteína ácida fibrilar glial (gfap) e/ou a hidrolase carbóxi-terminal da ubiquitina l1 (uch-l1)
|
EP3725796A4
(de)
|
2017-12-15 |
2021-09-15 |
Chugai Seiyaku Kabushiki Kaisha |
Verfahren zur herstellung von peptid und verfahren zur verarbeitung von basen
|
EP3728310A1
(de)
|
2017-12-18 |
2020-10-28 |
VIIV Healthcare UK (No.5) Limited |
Antigenbindende polypeptide
|
CN111819197A
(zh)
|
2018-03-12 |
2020-10-23 |
硕腾服务有限责任公司 |
抗ngf抗体及其方法
|
CN112236450A
(zh)
|
2018-03-26 |
2021-01-15 |
根路径基因组学公司 |
靶结合部分的组合物及使用方法
|
KR20210098476A
(ko)
|
2018-11-30 |
2021-08-10 |
추가이 세이야쿠 가부시키가이샤 |
펩티드 화합물 또는 아마이드 화합물의 탈보호법 및 고상 반응에 있어서의 탈수지 방법, 및 펩티드 화합물의 제조 방법
|
ES2956413T3
(es)
*
|
2019-02-15 |
2023-12-20 |
Atreca Inc |
Anticuerpos que se unen al tejido tumoral y sus usos para diagnóstico y terapia
|
CN113874392A
(zh)
|
2019-03-28 |
2021-12-31 |
丹尼斯科美国公司 |
工程化抗体
|
JP7397884B2
(ja)
|
2019-05-09 |
2023-12-13 |
ジェネンテック, インコーポレイテッド |
抗体の作製方法
|
AU2020329290A1
(en)
|
2019-08-13 |
2022-03-24 |
Elpis Biopharmaceuticals |
Engineered interleukin-2 receptor beta agonists
|
EP4055185A1
(de)
|
2019-11-08 |
2022-09-14 |
10X Genomics, Inc. |
Räumlich markierte analytfänger für analyt-multiplexing
|
CA3167027A1
(en)
|
2020-02-05 |
2021-08-12 |
Larimar Therapeutics, Inc. |
Tat peptide binding proteins and uses thereof
|
JP2023515633A
(ja)
|
2020-02-28 |
2023-04-13 |
ブリストル-マイヤーズ スクイブ カンパニー |
放射性標識されたフィブロネクチンに基づく足場および抗体ならびにそのセラノスティクス的使用
|
EP4136459A1
(de)
|
2020-04-13 |
2023-02-22 |
Abbott Laboratories |
Verfahren, komplexe und kits zum nachweis oder zur bestimmung einer menge eines ss-coronavirus-antikörpers in einer probe
|
WO2022026577A1
(en)
|
2020-07-31 |
2022-02-03 |
Nantbio, Inc. |
Chimeric t cell receptors, nucleic acids, and methods of making and using the same
|
CA3188349A1
(en)
|
2020-08-04 |
2022-02-10 |
A. Scott Muerhoff |
Improved methods and kits for detecting sars-cov-2 protein in a sample
|
WO2022104001A1
(en)
|
2020-11-13 |
2022-05-19 |
Bristol-Myers Squibb Company |
Expanded protein libraries and uses thereof
|
WO2022119841A1
(en)
|
2020-12-01 |
2022-06-09 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
WO2023102384A1
(en)
|
2021-11-30 |
2023-06-08 |
Abbott Laboratories |
Use of one or more biomarkers to determine traumatic brain injury (tbi) in a subject having received a head computerized tomography scan that is negative for a tbi
|
AU2021409136A1
(en)
|
2020-12-21 |
2023-06-29 |
10X Genomics, Inc. |
Methods, compositions, and systems for capturing probes and/or barcodes
|
WO2022147147A1
(en)
|
2020-12-30 |
2022-07-07 |
Abbott Laboratories |
Methods for determining sars-cov-2 antigen and anti-sars-cov-2 antibody in a sample
|
WO2022159771A1
(en)
|
2021-01-22 |
2022-07-28 |
Elpis Biopharmaceuticals |
Anti-pd-l1 monoclonal antibodies and fusion proteins with interleukin-15 (il-15), interleukin-15 receptor 15 alpha or interleukin-2
|
US11792839B2
(en)
|
2021-03-12 |
2023-10-17 |
Eagle Technology, Llc |
Systems and methods for controlling communications based on machine learned information
|
AU2022238446A1
(en)
|
2021-03-18 |
2023-09-07 |
10X Genomics, Inc. |
Multiplex capture of gene and protein expression from a biological sample
|
BR112023024169A2
(pt)
|
2021-05-18 |
2024-02-06 |
Abbott Lab |
Métodos para avaliar lesão cerebral em um indivíduo pediátrico
|
CA3222291A1
(en)
|
2021-06-14 |
2022-12-22 |
Jaime MARINO |
Methods of diagnosing or aiding in diagnosis of brain injury caused by acoustic energy, electromagnetic energy, an over pressurization wave, and/or blast wind
|
WO2023034777A1
(en)
|
2021-08-31 |
2023-03-09 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023056268A1
(en)
|
2021-09-30 |
2023-04-06 |
Abbott Laboratories |
Methods and systems of diagnosing brain injury
|
WO2023114978A1
(en)
|
2021-12-17 |
2023-06-22 |
Abbott Laboratories |
Systems and methods for determining uch-l1, gfap, and other biomarkers in blood samples
|
WO2023129942A1
(en)
|
2021-12-28 |
2023-07-06 |
Abbott Laboratories |
Use of biomarkers to determine sub-acute traumatic brain injury (tbi) in a subject having received a head computerized tomography (ct) scan that is negative for a tbi or no head ct scan
|
WO2023150652A1
(en)
|
2022-02-04 |
2023-08-10 |
Abbott Laboratories |
Lateral flow methods, assays, and devices for detecting the presence or measuring the amount of ubiquitin carboxy-terminal hydrolase l1 and/or glial fibrillary acidic protein in a sample
|
WO2023220597A1
(en)
|
2022-05-10 |
2023-11-16 |
Elpis Biopharmaceuticals |
Engineered interleukin-2 receptor beta reduced-binding agonist
|
WO2024006876A1
(en)
|
2022-06-29 |
2024-01-04 |
Abbott Laboratories |
Magnetic point-of-care systems and assays for determining gfap in biological samples
|
WO2024059708A1
(en)
|
2022-09-15 |
2024-03-21 |
Abbott Laboratories |
Biomarkers and methods for differentiating between mild and supermild traumatic brain injury
|